Thus, we hypothesized that the elevated levels of YKL-40 in CSF of AD [17–24] and FTLD [20, 21, 23, 26–29] patients reflect neuroinflammatory changes in the brain areas that are typically affected in these dementia types. This evidence concerns the gene CHI3L1 and Alzheimer disease.